Reforming Accountable Care Organizations
Experts explore opportunities to reduce costs and promote health equity.
A Review of Health Care in the Court
Several U.S. Supreme Court cases from this past term have significant implications for the provision of medical care.
Sniffing Out New Regulation
Scholars propose to modify the current regulatory regime for animal-based medical diagnostics.
Hidden Racial Disparities in FDA-Required Research
Current testing practices in the pharmaceutical industry exploit social and racial inequities.
Race and Regulation
Experts examine how regulatory policies disproportionately affect communities of color.
China’s Administrative State Is Both a Blessing and a Curse
China’s approach to regulatory law has both helped and hindered the government’s response to COVID-19.
The U.K. Races to Catch Up on COVID-19
The United Kingdom’s lockdown measures prompt questions of its legality.
Israel Pushes Its Emergency Powers to Their Limits
Israel’s executives have authority to combat COVID-19, but they appear to be abusing their power.
Exporting the Italian Model to Fight COVID-19
Italy’s early missteps in responding to the coronavirus can teach the world lessons on responding to pandemics.
Reforming Regulation to Promote Medical Use of Psychedelic Drugs
Expert argues for altering regulations on psychedelic drugs to treat mental illness and addiction.
How Regulators Can Increase Price Competition in Health Care
Scholars urge regulators to help level the playing field in contracting between health plans and hospitals.
New Approach to Affordable Care Act Waivers Causes Controversy
The Trump Administration encourages states to use “innovation waivers” to find new ways to lower costs.